Skip to main content
Elsevier

Nontuberculous Mycobacteria (NTM)

Microbiological, Clinical and Geographical Distribution

  • 1st Edition - January 10, 2019
  • Latest edition
  • Editors: Ali Akbar Velayati, Parissa Farnia
  • Language: English

Nontuberculous Mycobacteria (NTM): Microbiological, Clinical and Geographical Distribution is a complete reference that stimulates a greater understanding of NTM infection… Read more

Description

Nontuberculous Mycobacteria (NTM): Microbiological, Clinical and Geographical Distribution is a complete reference that stimulates a greater understanding of NTM infections. Sections cover microbiologic and molecular diagnostic tools, drug susceptibility tests, human genetic susceptibility, prevalence and incidence studies, clinical and radiological presentations, and clinical trials for antibiotic therapy. With the incidence rate of NTM infections increasing globally during the last decade, significant mortality and morbidity must be addressed. This important reference will provide research scientists, clinical microbiologists, hospital diagnostic technicians, and post graduate medical and science students with information on the epidemiology, prevalence, microbiology and clinical aspects of NTM.

Key features

  • Highlights new findings in the epidemiological distribution and new diagnosis and treatment protocol of mycobacterial infections
  • Debates new advances in the detection of NTM
  • Demonstrates the distribution of NTM in the environment and its relationship with human infection using a geographical information system (GIS)
  • Includes new radiological findings in non-tuberculous mycobacterial infections in the lung using CT and PET-Scan imaging

Readership

Research scientists, clinical microbiologists and hospital diagnostic technicians, postgraduate medical and science students from third year of study onwards

Table of contents

1. The Taxonomy of the Genus Mycobacterium
Enrico-Tortoli

2. Identification of Non-Tuberculous Mycobacterium: Conventional versus Rapid Molecular Tests
Ali Akbar Velayati, Parissa Farina, Shima Saif

3. Susceptibility Testing of Nontuberculous Mycobacteria
Imran Ahmed, Rumina Hasan, Sadia Shakoor

4. Future Nontuberculous Mycobacteria DST and Therapeutic Interventions
Sven Hoffner, Diane Ordway

5. Nontuberculous Mycobacterial Diseases in Humans
Lars-Olof. Larsson, Rutger Bennet, Margareta Eriksson, Bodil Jonsson and Malin Ridell

6. Nontuberculous Mycobacterial Lung Disease
Ruxana T. Sadikot

7. Clinical Presentation of Nontuberculous Mycobacteria Using Radiological and CT-Scan Imagining
Payam Mehrian, Poopak Farnia, Jalaledin Ghanavi, Hamidreza Jamaati, Payam Tabarsi, Ali Akbar Velayati

8. Mapping the Footprints of Nontuberculosis Mycobacteria: A Diagnostic Dilemma
Mandira Varma-Basil, Mridula Bose

9. Nosocomial and Healthcare-Associated NTM Infections and Their Control
Sadia Shakoor, Maria Owais, Rumina Hasan and Seema Irfan

10. Epidemiological Distribution of Nontuberculous Mycobacteria using Geographical Information System
Parissa Farnia, Poopak Farina, Jaladein Ghanavi, Ali Akbar Velayati

Product details

  • Edition: 1
  • Latest edition
  • Published: January 10, 2019
  • Language: English

About the editors

AV

Ali Akbar Velayati

Dr. Ali Akbar Velayati is the Director of the National Research Institute of Tuberculosis and Lung Diseases (NRITLD) at the Shahid Beheshti University of Medical Sciences. He is a Full Professor of Pediatric Infectious Diseases, and he has guided more than 300 MD and PhD students. He is also the Head of Mycobacteriology Research Center (MRC) in NRITLD, where he directly monitors the basic and clinical trial on tuberculosis. Dr. Velayati is the President of the Asian African Society of Mycobacteriology and of the Society of Biomedical and Biotechnology Scientists. He is the Chief Editor of the International Journal of Mycobacteriology, the Journal of Preventive, Diagnostic and Treatment Strategies in Medicine, and the Biomedical and Biotechnology Research Journal.
Affiliations and expertise
Director, National Research Institute of Tuberculosis and Lung Disease (NRITLD), WHO Collaborating Centre, Shahid Beheshti University of Medical Sciences, Tehran, Iran

PF

Parissa Farnia

Dr. Parissa Farnia is the Director of the Iranian National Reference Tuberculosis Laboratory (INRT) at the Mycobacteriology Research Center (MRC) in the National Research Institute of Tuberculosis and Lung Disease (NRITLD). Her expertise and research interests include mycobacteriology, infectious diseases, and tuberculosis. She has published in multiple international journals such as Journal of Clinical Microbiology, Chest, Clinical infectious Diseases, and the International Journal of Tuberculosis and Lung Disease and serves on several editorial boards including International Journal of Mycobacteriology, the Journal of Preventive, Diagnostic and Treatment Strategies in Medicine, and the Biomedical and Biotechnology Research Journal.
Affiliations and expertise
Director, Mycobacteriology Research Center (MRC), National Research Institute of Tuberculosis and Lung Disease (NRITLD), WHO Collaborating Centre, Shahid Beheshti University of Medical Sciences, Tehran, Iran

View book on ScienceDirect

Read Nontuberculous Mycobacteria (NTM) on ScienceDirect